Kennedy Investment Group’s AbbVie ABBV Stock Holding History

Kennedy Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.96M	Buy	15,754 +387	+3%	+$83.3K	1.35%	17
2026 Q1	$3.34M	Buy	15,367 +234	+2%	+$51.9K	1.31%	15
2025 Q4	$3.46M	Buy	15,133 +6	+0%	+$1.37K	1.3%	15
2025 Q3	$3.5M	Sell	15,127 -12	-0.1%	-$2.44K	1.39%	15
2025 Q2	$2.81M	Sell	15,139 -92	-0.6%	-$17.1K	1.19%	22
2025 Q1	$3.19M	Sell	15,231 -169	-1%	-$32.9K	1.48%	17
2024 Q4	$2.74M	Buy	15,400 +1,732	+13%	+$318K	1.24%	18
2024 Q3	$2.7M	Sell	13,668 -43	-0.3%	-$8.03K	1.24%	18
2024 Q2	$2.35M	Buy	13,711 +729	+6%	+$121K	1.19%	22
2024 Q1	$2.36M	Sell	12,982 -934	-7%	-$161K	1.26%	19
2023 Q4	$2.16M	Buy	13,916 +1,354	+11%	+$197K	1.21%	23
2023 Q3	$1.87M	Sell	12,562 -673	-5%	-$98.8K	1.13%	25
2023 Q2	$1.78M	Sell	13,235 -1,337	-9%	-$196K	1.04%	27
2023 Q1	$2.32M	Buy	14,572 +79	+0.5%	+$12.1K	1.42%	21
2022 Q4	$2.34M	Buy	+14,493	New	+$2.22M	1.49%	20

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kennedy Investment Group's ABBV Position: Q2 2026 in Review

Kennedy Investment Group increased its AbbVie (ABBV) stake by 2.5% in Q2 2026, buying an estimated $83.3K and bringing the position to 15,754 shares worth $3.96M. The position accounts for 1.35% of the portfolio, ranked #17.

Kennedy Investment Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Kennedy Investment Group held 15,754 shares of AbbVie worth $3.96M as of Q2 2026.
Kennedy Investment Group bought 387 AbbVie shares in Q2 2026, an estimated $83.3K.
AbbVie made up 1.35% of Kennedy Investment Group's portfolio in Q2 2026, its #17 holding.
Kennedy Investment Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kennedy Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.